[Chondrocalcinosis revealing familial hypocalciuric hypercalcemia: about one observation].

Pan Afr Med J

Service de Médecine Interne, CHU Hédi Chaker, 3029 Sfax, Tunisie.

Published: May 2016

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449982PMC
http://dx.doi.org/10.11604/pamj.2015.20.58.5828DOI Listing

Publication Analysis

Top Keywords

[chondrocalcinosis revealing
4
revealing familial
4
familial hypocalciuric
4
hypocalciuric hypercalcemia
4
hypercalcemia observation]
4
[chondrocalcinosis
1
familial
1
hypocalciuric
1
hypercalcemia
1
observation]
1

Similar Publications

Article Synopsis
  • CPPD disease is a significant cause of arthritis that can resemble other rheumatic conditions, making accurate diagnosis crucial.
  • A deep-learning algorithm was developed and tested to automatically detect CPPD features in hand radiographs, focusing specifically on certain joint areas.
  • The combined model for detecting CPPD showed strong performance metrics, with a mean AUROC of 0.86 and good sensitivity and specificity, while separate models for different joint areas had varying success rates.
View Article and Find Full Text PDF
Article Synopsis
  • A study estimated how common chondrocalcinosis and CPPD are in patients with low alkaline phosphatase (ALP) levels and a genetic marker for hypophosphatasia (HPP), compared to those without the genetic marker.
  • Results showed that chondrocalcinosis was significantly more prevalent in the genetically positive (+GT) group (21.4%) than in the negative (-GT) group (5.6%).
  • The findings suggest that chondrocalcinosis is common in HPP patients, and it's important to consider genetic factors when diagnosing related conditions.
View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to compare the effectiveness and safety of 10-mg and 30-mg daily doses of prednisolone for treating acute calcium pyrophosphate (CPP) crystal arthritis.
  • In this trial, 79 patients received either dose for 7 days, with the primary focus on symptom resolution time and secondary outcomes including recurrence rates and adverse events.
  • Results showed no significant differences between the two doses in terms of symptom resolution time, recurrence rates, or safety, indicating that both doses are equally effective for managing acute CPP crystal arthritis.
View Article and Find Full Text PDF
Article Synopsis
  • A case report describes a rare occurrence of pseudogout in a 55-year-old man, who presented with severe low-back pain and fever, initially misdiagnosed as a spinal infection.
  • Imaging showed lumbar spondylosis, but an MRI revealed a cystic lesion at the lumbar joint, leading to further testing that confirmed calcium pyrophosphate crystals.
  • Successful treatment with oral colchicine provided rapid pain relief, illustrating the need for thorough investigations to accurately diagnose rare conditions and avoid unnecessary treatments.
View Article and Find Full Text PDF

Acute Neck Pain from Crowned Dens Syndrome: A Case Report and Clinical Insights.

Am J Case Rep

August 2024

Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Article Synopsis
  • Crowned dens syndrome (CDS) is a rare condition where calcium pyrophosphate crystals form a calcified 'crown' on the second cervical vertebra, leading to neck pain and symptoms similar to meningitis.
  • A case report details a 62-year-old man who experienced severe headaches and neck pain, ultimately diagnosed with CDS through CT scan, and responded well to treatment with NSAIDs.
  • The report emphasizes the need for increased awareness of CDS among clinicians to reduce misdiagnosis, especially in older patients with new neck pain and a history of pseudogout, and calls for further research on its diagnosis and treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!